Intensity Therapeutics is a Qualified Connecticut Business
Intensity Therapeutics' is a "Qualified Connecticut Business" (QCB) as approved by CT Innovations. The State of Connecticut launched a program in 2010 that allows Angels providing capital to QCBs to take a credit against Connecticut State income tax for certain investments made in qualifying businesses. Investments must be at least $25,000 to be considered under the Program and the income tax credit equals 25% of the cash investment up to a maximum credit of $250,000.
Intensity Therapeutics is a clinical development stage company that is conducting human clinical testing of its lead product INT230-6 in refractory solid tumor cancers. The Company is interested in collaborating with pharmaceutical, imaging or biotechnology companies.
Who we are
Intensity Therapeutics is a clinical development stage company. We are seeking partnerships/investors interested in advancing the company’s anti-cancer platform technology and lead product INT230-6.